Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Petrini, P.

Search results

  • RSS Feed
(1 - 9 of 9)
Inhibitors in nonsevere haemophilia A: outcome and eradication strategies
Velzen, A.S. van; Eckhardt, C.L.; Hart, D.P.; Peters, M.; Rangarajan, S.; Mancuso, M.E.; ... ; INSIGHT Study Grp 2015
Inhibitors in nonsevere haemophilia A: outcome and eradication strategies
Article / Letter to editor
metadata only
Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis
Velzen, A.S. van; Eckhardt, C.L.; Streefkerk, N.; Peters, M.; Astermark, J.; Brons, P.P.; ... ; INSIGHT Study Grp 2014
Inhibitors increase the burden of disease in nonsevere haemophilia A patients - treatment strategies to obtain hemostasis
Article / Letter to editor
metadata only
Prediction of DDAVP response in 850 non-severe hemophilia A patients
Loomans, J.I.; Velzen, A.S. van; Eckhardt, C.L.; Peters, M.; Astermark, J.; Brons, P.P.; ... ; Rise Study Grp 2014
Prediction of DDAVP response in 850 non-severe hemophilia A patients
Article / Letter to editor
metadata only
Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser)
Loomans, J.I.; Velzen, A.S. van; Eckhardt, C.L.; Peters, M.; Astermark, J.; Brons, P.P.; ... ; Insight Rise Study Grp 2014
Von Willebrand Factor antigen and age explain variation in baseline FVIII:C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser)
Article / Letter to editor
metadata only
Clinical presentation of inhibitor development in non-severe hemophilia A: half of patients have high titer inhibitors and present with bleeding complications
Eckhardt, C.L.; Loomans, J.I.; Velzen, A.S. van; Peters, M.; Astermark, J.; Brons, P.P.; ... ; Insight Study Grp 2014
Clinical presentation of inhibitor development in non-severe hemophilia A: half of patients have high titer inhibitors and present with bleeding complications
Article / Letter to editor
metadata only
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Eckhardt, C.L.; Velzen, A.S. van; Peters, M.; Astermark, J.; Brons, P.P.; Castaman, G.; ... ; INSIGHT Study Grp 2013
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Article / Letter to editor
metadata only
Inhibitor eradication therapy in non-severe hemophilia A
Velzen, A.S. van; Eckhardt, C.L.; Peters, M.; Hart, P.; Rangarajan, S.; Hay, C.R.M.; ... ; INSIGHT Consortium 2013
Inhibitor eradication therapy in non-severe hemophilia A
Article / Letter to editor
metadata only
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Gouw, S.C.; Berg, H.M. van den; Fischer, K.; Auerswald, G.; Carcao, M.; Chalmers, E.; ... ; Res Determinants INhibitor Dev 2013
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Article / Letter to editor
metadata only
Inhibitor Eradication Therapy in Non-Severe Hemophilia A
Velzen, A. van; Peters, M.; Hart, D.; Rangarajan, S.; Hay, C.; Mancuso, M.; ... ; Yee, T. 2012
Inhibitor Eradication Therapy in Non-Severe Hemophilia A
Article / Letter to editor
metadata only